Interim analysis of the randomized PATSGO trial evaluating the prolongation of adjuvant temozolomide in newly diagnosed glioblastoma patients.Jean‐François Baurain, Laurette Renard, G Cosnard et al.|Journal of Clinical Oncology|2010Cited by 2
8744 POSTER Extended Use of Adjuvant TMZ in Newly Diagnosed GBM Patients is Safe – Results From the Safety Analysis of the PATSGO TrialF. Hammouch, J.F. Baurain, Tom Boterberg et al.|European Journal of Cancer|2011Cited by 1